These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21059181)

  • 21. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.
    Muntjewerff JW; Gellekink H; den Heijer M; Hoogendoorn ML; Kahn RS; Sinke RJ; Blom HJ
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):99-106. PubMed ID: 17716874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between catechol-O-methyltransferase polymorphism and vitiligo.
    Türsen U; Kaya TI; Erdal ME; Derici E; Gündüz O; Ikizoğlu G
    Arch Dermatol Res; 2002 May; 294(3):143-6. PubMed ID: 12029502
    [No Abstract]   [Full Text] [Related]  

  • 23. A functional polymorphism in the disrupted-in schizophrenia 1 gene is associated with chronic fatigue syndrome.
    Fukuda S; Hashimoto R; Ohi K; Yamaguti K; Nakatomi Y; Yasuda Y; Kamino K; Takeda M; Tajima S; Kuratsune H; Nishizawa Y; Watanabe Y
    Life Sci; 2010 May; 86(19-20):722-5. PubMed ID: 20227423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association study of heroin dependence and catechol-O-methyltransferase gene].
    Cao L; Li T; Liu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):127-30. PubMed ID: 12673581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy.
    Anttila S; Huuhka K; Huuhka M; Illi A; Rontu R; Leinonen E; Lehtimäki T
    Pharmacogenomics J; 2008 Apr; 8(2):113-6. PubMed ID: 17700596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior.
    Tochigi M; Suzuki K; Kato C; Otowa T; Hibino H; Umekage T; Kato N; Sasaki T
    Pharmacogenet Genomics; 2007 Oct; 17(10):867-72. PubMed ID: 17885625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene].
    Zhang XN; Ruan LM; Le YP; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):322-4. PubMed ID: 12903043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The catechol-O-methyltransferase gene: its regulation and polymorphisms.
    Tunbridge EM
    Int Rev Neurobiol; 2010; 95():7-27. PubMed ID: 21095457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.
    Lachman HM; Morrow B; Shprintzen R; Veit S; Parsia SS; Faedda G; Goldberg R; Kucherlapati R; Papolos DF
    Am J Med Genet; 1996 Sep; 67(5):468-72. PubMed ID: 8886163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
    Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
    Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic polymorphism of COMT in mental disorders].
    Tylec A; Stryjecka-Zimmer M; Kucharska-Pietura K
    Psychiatr Pol; 2007; 41(4):473-83. PubMed ID: 18046978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia.
    Maloney EM; Boneva RS; Lin JM; Reeves WC
    Metabolism; 2010 Sep; 59(9):1351-7. PubMed ID: 20102774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics.
    Nolan KA; Czobor P; Citrome LL; Krakowski M; Lachman HM; Kennedy JL; Ni X; Lieberman J; Chakos M; Volavka J
    J Clin Psychopharmacol; 2006 Jun; 26(3):338-40. PubMed ID: 16702905
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome.
    Maltese PE; Venturini L; Poplavskaya E; Bertelli M; Cecchin S; Granato M; Nikulina SY; Salmina A; Aksyutina N; Capelli E; Ricevuti G; Lorusso L
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms of adrenergic receptors.
    Garland EM; Biaggioni I
    Clin Auton Res; 2001 Apr; 11(2):67-78. PubMed ID: 11570606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of adrenergic receptors: variations on a theme.
    Liggett SB
    Assay Drug Dev Technol; 2003 Apr; 1(2):317-26. PubMed ID: 15090197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenergic signaling polymorphisms and their impact on cardiovascular disease.
    Dorn GW
    Physiol Rev; 2010 Jul; 90(3):1013-62. PubMed ID: 20664078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of adrenergic receptors.
    Hall IP; Wheatley AP; Dewar JC
    Methods Mol Biol; 2000; 126():117-26. PubMed ID: 10685405
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic modulation of adrenergic activity in the heart and vasculature: implications for perioperative medicine.
    Zaugg M; Schaub MC
    Anesthesiology; 2005 Feb; 102(2):429-46. PubMed ID: 15681962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic fatigue syndrome].
    Miike T
    Nihon Rinsho; 2001 Dec; 59 Suppl 8():414-21. PubMed ID: 11808256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.